310 related articles for article (PubMed ID: 23382571)
81. Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
Han WM; Bijker R; Chandrasekaran E; Pujari S; Ng OT; Ly PS; Lee MP; Van Nguyen K; Chan YJ; Do CD; Choi JY; Chaiwarith R; Merati TP; Kiertiburanakul S; Azwa I; Khusuwan S; Zhang F; Gani YM; Tanuma J; Sangle S; Ditangco R; Yunihastuti E; Ross J; Avihingsanon A;
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):489-497. PubMed ID: 33136750
[TBL] [Abstract][Full Text] [Related]
82. The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study.
Ryom L; Lundgren JD; Reiss P; Ross M; Kirk O; Fux CA; Morlat P; Fontas E; Smith C; De Wit S; d'Arminio Monforte A; El Sadr W; Hatleberg C; Phillips A; Sabin C; Law M; Mocroft A
J Infect Dis; 2021 Feb; 223(4):632-637. PubMed ID: 32640015
[TBL] [Abstract][Full Text] [Related]
83. Estimated Glomerular Filtration Rate and the Risk of Cancer.
Xu H; Matsushita K; Su G; Trevisan M; Ärnlöv J; Barany P; Lindholm B; Elinder CG; Lambe M; Carrero JJ
Clin J Am Soc Nephrol; 2019 Apr; 14(4):530-539. PubMed ID: 30872279
[TBL] [Abstract][Full Text] [Related]
84. Interaction of sex and HIV infection on renal impairment: baseline evidence from the CHART cohort.
Shi R; Chen X; Lin H; Shen W; Xu X; Zhu B; Xu X; Ding Y; He N
Int J Infect Dis; 2022 Mar; 116():182-188. PubMed ID: 35017104
[TBL] [Abstract][Full Text] [Related]
85. Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration.
Poda A; Kabore NF; Malateste K; De Rekeneire N; Semde A; Bikinga Y; Patassi A; Chenal H; Messou E; Dabis F; Ekouevi DK; Jaquet A; Cournil A
HIV Med; 2021 Feb; 22(2):113-121. PubMed ID: 33145918
[TBL] [Abstract][Full Text] [Related]
86. Renal insufficiency and mortality in patients with known or suspected coronary artery disease.
van Domburg RT; Hoeks SE; Welten GM; Chonchol M; Elhendy A; Poldermans D
J Am Soc Nephrol; 2008 Jan; 19(1):158-63. PubMed ID: 18178803
[TBL] [Abstract][Full Text] [Related]
87. Association of impaired kidney function with mortality in rural Uganda: results of a general population cohort study.
Kalyesubula R; Sekitoleko I; Tomlin K; Hansen CH; Ssebunya B; Makanga R; Mbonye MK; Seeley J; Smeeth L; Newton R; Tomlinson LA
BMJ Open; 2022 Apr; 12(4):e051267. PubMed ID: 35473721
[TBL] [Abstract][Full Text] [Related]
88. Changes in Urinary Biomarkers Over 10 Years Is Associated With Viral Suppression in a Prospective Cohort of Women Living With HIV.
Baxi SM; Scherzer R; Jotwani V; Estrella MM; Abraham AG; Parikh CR; Bennett MR; Cohen MH; Nowicki MJ; Gustafson DR; Sharma A; Young MA; Shlipak MG;
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):e138-e145. PubMed ID: 27759575
[TBL] [Abstract][Full Text] [Related]
89. Incidence of impaired kidney function among people with HIV: a systematic review and meta-analysis.
Shi R; Chen X; Lin H; Ding Y; He N
BMC Nephrol; 2022 Mar; 23(1):107. PubMed ID: 35300612
[TBL] [Abstract][Full Text] [Related]
90. Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIV.
Roen AO; Peters L; Wandeler G; van der Valk M; Zangerle R; Günthard HF; Wit F; Mussini C; De Wit S; d'Arminio Monforte A; Vehreschild JJ; Castagna A; Jaschinski N; Vannappagari V; Chen L; Tallada J; C'mar J; Mocroft A; Ryom L
Open Forum Infect Dis; 2024 Jun; 11(6):ofae308. PubMed ID: 38919512
[TBL] [Abstract][Full Text] [Related]
91. Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.
Krishnan S; Wu K; Smurzynski M; Bosch RJ; Benson CA; Collier AC; Klebert MK; Feinberg J; Koletar SL;
HIV Clin Trials; 2011; 12(4):190-200. PubMed ID: 22044855
[TBL] [Abstract][Full Text] [Related]
92. Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores.
Dietrich LG; Thorball CW; Ryom L; Burkhalter F; Hasse B; Thurnheer MC; Weisser M; Schmid P; Bernasconi E; Darling KEA; Buvelot H; Fellay J; Ledergerber B; Tarr PE;
J Infect Dis; 2021 Jun; 223(12):2145-2153. PubMed ID: 33151293
[TBL] [Abstract][Full Text] [Related]
93. Prevalence and Evolution of Renal Impairment in People Living With HIV in Rural Tanzania.
Mapesi H; Kalinjuma AV; Ngerecha A; Franzeck F; Hatz C; Tanner M; Mayr M; Furrer H; Battegay M; Letang E; Weisser M; Glass TR;
Open Forum Infect Dis; 2018 Apr; 5(4):ofy072. PubMed ID: 29707599
[TBL] [Abstract][Full Text] [Related]
94. Discontinuation of Proton Pump Inhibitors in Patients With Chronic Kidney Disease.
Mertz A; Cooney D; Rahman M; Lacey C; Burant CJ; Desai N
Hosp Pharm; 2021 Aug; 56(4):308-313. PubMed ID: 34381266
[No Abstract] [Full Text] [Related]
95. Association of marijuana, tobacco and alcohol use with estimated glomerular filtration rate in women living with HIV and women without HIV.
Fisher MC; Hoover DR; Shi Q; Sharma A; Estrella MM; Adimora A; Alcaide M; Collins LF; French A; Gao W; Koletar SL; Mcfarlane SI; Mckay H; Dionne JA; Palella F; Sarkar S; Spence A; Witt MD; Ross MJ
AIDS; 2023 Aug; 37(10):1555-1564. PubMed ID: 37352493
[TBL] [Abstract][Full Text] [Related]
96. Drug-Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives.
Cottura N; Kinvig H; Grañana-Castillo S; Wood A; Siccardi M
J Clin Pharmacol; 2022 Jul; 62(7):835-846. PubMed ID: 34990024
[TBL] [Abstract][Full Text] [Related]
97. Renal Impairment Impact and Survival Analysis in a Romanian Cohort of HIV-1(F1)-Infected Children and Adolescents.
Isac R; Costa R; Frandes M; Lazureanu VE; Stroescu RF; Steflea RM; Bagiu IC; Horhat FG; Chicin GN; Roberta AC; Cornelia PA; Doros G; Gafencu M
Life (Basel); 2023 Mar; 13(4):. PubMed ID: 37109416
[TBL] [Abstract][Full Text] [Related]
98. Factors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without Hypertension.
Dlamini SB; Wu MT; Dahms HU
Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078765
[TBL] [Abstract][Full Text] [Related]
99. Where what is not stated or required may be the most illuminating.
Lin J
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1826-8. PubMed ID: 25359388
[No Abstract] [Full Text] [Related]
100. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
Mocroft A; Lundgren JD; Ross M; Fux CA; Reiss P; Moranne O; Morlat P; Monforte Ad; Kirk O; Ryom L;
Lancet HIV; 2016 Jan; 3(1):e23-32. PubMed ID: 26762990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
